[1]牛佳莉,陆美茵,刘 斌.实验室检查指标对于多囊卵巢综合征患者排卵障碍的筛查效能[J].医学信息,2023,36(03):93-97.[doi:10.3969/j.issn.1006-1959.2023.03.019]
　NIU Jia-li,LU Mei-yin,LIU Bin.Efficacy of Laboratory Test Indicators for Screening Ovulation Disorders in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2023,36(03):93-97.[doi:10.3969/j.issn.1006-1959.2023.03.019]
点击复制

实验室检查指标对于多囊卵巢综合征患者排卵障碍的筛查效能()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年03期
页码:
93-97
栏目:
论著
出版日期:
2023-02-01

文章信息/Info

Title:
Efficacy of Laboratory Test Indicators for Screening Ovulation Disorders in Patients with Polycystic Ovary Syndrome
文章编号:
1006-1959（2023）03-0093-05
作者:
牛佳莉; 陆美茵; 刘 斌
（1.遵义医科大学珠海校区研究生院，广东 珠海 519000；2.深圳市宝安区妇幼保健院生物样本库，广东 深圳 518102）
Author(s):
NIU Jia-li; LU Mei-yin; LIU Bin
(1.Graduate School of Zunyi Medical University Zhuhai Campus,Zhuhai 519000,Guangdong,China;2.Department of Biobank,Shenzhen Bao’an Women’s and Children’s Hospital,Shenzhen 518102,Guangdong,China)
关键词:
多囊卵巢综合征; 排卵障碍; 抑制素B; 胰岛素抵抗
Keywords:
Polycystic ovary syndrome; Ovulation disorders; Inhibin B; Insulin resistance
分类号:
R581.2；R711.75
DOI:
10.3969/j.issn.1006-1959.2023.03.019
文献标志码:
A
摘要:
目的 探讨实验室化验指标对多囊卵巢综合征（PCOS）患者排卵障碍的筛查价值。方法 选取2019年8月-2021年12月初次确诊的多囊卵巢综合征患者140例，根据有无排卵障碍将其分为有排卵障碍组和无排卵障碍组，收集其临床信息及各项实验室检查指标[抑制素B（INHB）、抗缪勒氏激素、同型半胱氨酸（Hcy）、性激素6项、胰岛素和血糖]，分析其相关性。后将上述患者按100∶40分为发现组和验证组，进行受试者工作特性曲线（ROC）分析，明确实验室检查指标对于排卵障碍的筛查效能。结果 有排卵障碍组和无排卵障碍组的INHB与胰岛素抵抗稳态模型（HOMA-IR）比较，差异有统计学意义（P＜0.05）；ROC曲线显示，发现组中INHB诊断排卵障碍的灵敏度和特异度为66.07%、52.27%，AUC面积0.587，HOMA-IR诊断排卵障碍的灵敏度和特异度为53.57%、63.18%，AUC为0.618，两者合并后的特异度为72.73%，AUC为0.650，同型半胱氨酸（Hcy）筛查PCOS患者排卵障碍的特异度为97.73%；根据得出的临界值（Cut-off）进行验证，验证组结果显示，INHB诊断排卵障碍的灵敏度和特异度为65.00%、50.00%，HOMA-IR诊断排卵障碍的灵敏度和特异度为55.00%、65.00%，Hcy的特异度为95.00%。结论 INHB及HOMA-IR可作为筛查PCOS患者排卵障碍的实验室指标，结合Hcy可提高其准确率，有助于监控重点患者、早期干预，及保护患者的生育力。
Abstract:
Objective To investigate the value of laboratory tests for screening ovulation disorders in patients with polycystic ovary syndrome (PCOS).Methods A total of 140 patients with polycystic ovary syndrome who were initially diagnosed from August 2019 to December 2021 were selected. According to the presence or absence of ovulation disorder, they were divided into ovulation disorder group and non-ovulation disorder group. Their clinical information and various laboratory examination indicators [inhibin B (INHB), anti-Mullerian hormone, homocysteine (Hcy), six sex hormones, insulin and blood glucose ] were collected, and their correlation was analyzed. The above patients were divided into the discovery group and the verification group according to 100 : 40, and the receiver operating characteristic curve (ROC) analysis was performed to determine the screening efficacy of laboratory examination indicators for ovulation disorders.Results There was a statistically significant difference between INHB and insulin resistance homeostasis model (HOMA-IR) in the ovulatory disorder group and the non-ovulatory disorder group (P<0.05). ROC curve showed that the sensitivity and specificity of INHB in the diagnosis of ovulation disorders were 66.07% and 52.27%, and the AUC area was 0.587; the sensitivity and specificity of HOMA-IR in the diagnosis of ovulation disorders were 53.57% and 63.18%, and the AUC was 0.618; the combined specificity was 72.73%, and the AUC was 0.650; the specificity of homocysteine (Hcy) in screening ovulation disorders in PCOS patients was 97.73%. According to the Cut-off for verification, the results of the validation group showed that the sensitivity and specificity of INHB in the diagnosis of ovulation disorder were 65.00% and 50.00%, the sensitivity and specificity of HOMA-IR in the diagnosis of ovulation disorder were 55.00% and 65.00%, and the specificity of Hcy was 95.00%.Conclusion INHB and HOMA-IR can be used as laboratory indicators for screening ovulation disorders in PCOS patients. Hcy can improve its accuracy and help to monitor the key patients to early intervention, and protect the fertility of patients.

参考文献/References:

[1]多囊卵巢综合征相关不孕治疗及生育保护共识专家组,中华预防医学会生育力保护分会生殖内分泌生育保护学组.多囊卵巢综合征相关不孕治疗及生育保护共识[J].生殖医学杂志,2020,29(7):843-851.[2]Jiang NX,Li XL.The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms[J].Reprod Sci,2022,29(9):2465-2476.[3]吴雅楠,崔术,安明慧.育龄期排卵障碍性子宫出血患者的体质特点及干预措施[J].国医论坛,2022,37(4):26-29.[4]Carson SA,Kallen AN.Diagnosis and Management of Infertility:A Review[J].JAMA,2021,326(1):65-76.[5]中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志,2018,53(1):2-6.[6]Polak K,Czyzyk A,Simoncini T.New markers of insulin resistance in polycystic ovary syndrome [J].Journal of endocrinological investigation,2017,40(1):1-8.[7]朱艳,屈晓威.多囊卵巢综合征患者早期妊娠丢失与同型半胱氨酸水平的相关性研究[J].临床和实验医学杂志,2017,16(7):694-696.[8]李晓敏,黄文洁,卢永超.多囊卵巢综合征排卵障碍的发生机制[J].中国医药导刊,2021,23(7):486-490.[9]Yetim A,Yetim ?覶,Baｓ F.Anti-Müllerian Hormone and Inhibin-A,but not Inhibin-B or Insulin-Like Peptide-3,may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results[J].Journal of Clinical research in Pediatric Endocrinology,2016,8(3):288-297.[10]梁丁兮.AMH和INHB与多囊卵巢综合征患者性激素的关系及其应用价值[J].检验医学与临床,2017,14(15):2245-2247.[11]Cassar S,Teede HJ,Moran LJ.Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance,androgens,obesity and gonadotrophins[J].Clinical Endocrinology,2014,81(6):899-906.[12]Abraham Gnanadass S,Divakar Prabhu Y,Valsala Gopalakrishnan A.Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update[J].Archives of Gynecology and Obstetrics,2021,303(3):631-643.[13]Zhang F,Liu X L,Rong N.Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome[J].Journal of Huazhong University of Science and Technology Medical Sciences,2017,37(1):70-73.[14]Yding Andersen C.Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle[J].Molecular Human Reproduction,2017,23(1):16-24.[15]Robertson DM,Lee CH,Baerwald A.Interactions between serum FSH,inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age[J].Endocrinology, Diabetes & Metabolism,2021,4(2):e00172.[16]Rosenfield RL,Ehrmann DA.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited[J].Endocrine Reviews,2016,37(5):467-520.[17]Garzia E,Galiano V,Marfia G.Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients[J].Reproductive Biology and Endocrinology,2022,20(1):6.[18]Dai C,Fei Y,Li J.A Novel Review of Homocysteine and Pregnancy Complications [J].BioMed Research International,2021,2021:6652231.[19]Ota K,Takahashi T,Han A.Effects of MTHFR C677T polymorphism on vitamin D, homocysteine and natural killer cell cytotoxicity in women with recurrent pregnancy losses[J].Human Reproduction (Oxford, England),2020,35(6):1276-1287.

相似文献/References:

[1]袁 奔,潘 伟,罗淑红,等.体重指数对多囊卵巢综合征患者 人工授精妊娠结局影响[J].医学信息,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
　YUAN Ben,PAN Wei,LUO Shu-hong,et al.Effects of Body Mass Index on the Outcome of Artificial Insemination in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2018,31(03):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
[2]罗红财,沈 颖,黄莉珊,等.基于温肾助阳、暖宫温胞改善卵巢功能异常的机制分析[J].医学信息,2022,35(11):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
　LUO Hong-cai,SHEN Ying,HUANG Li-shan,et al.The Mechanism Analysis of Improve Symptoms Related to Ovarian Dysfunction Based on Warming Kidney and Helping Yang,Warming Baogong[J].Journal of Medical Information,2022,35(03):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
[3]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
　ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Journal of Medical Information,2019,32(03):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[4]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的 临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
　LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2018,31(03):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
[5]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
　CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2022,35(03):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[6]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
　ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Journal of Medical Information,2022,35(03):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[7]谢 丹.不同促排卵方案治疗多囊卵巢综合征不孕症的效果[J].医学信息,2020,33(18):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
　XIE Dan.The Effect of Different Ovulation Induction Programs on the Infertility of Polycystic Ovary Syndrome[J].Journal of Medical Information,2020,33(03):141.[doi:10.3969/j.issn.1006-1959.2020.18.046]
[8]朱 艳,周 琴,安 洁,等.脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究[J].医学信息,2020,33(22):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
　ZHU Yan,ZHOU Qin,AN Jie,et al.Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance[J].Journal of Medical Information,2020,33(03):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
[9]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
　WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Journal of Medical Information,2020,33(03):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[10]王争艳,宋发荣.中药月经周期疗法治疗PCOS不孕症的效果[J].医学信息,2020,33(20):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
　WANG Zheng-yan,SONG Fa-rong.The Effect of Chinese Medicine Menstrual Cycle Therapy on PCOS Infertility[J].Journal of Medical Information,2020,33(03):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
[11]罗爱莲.定坤丹联合达英-35对多囊卵巢综合征患者体征及体内激素水平的影响[J].医学信息,2024,37(17):127.[doi:10.3969/j.issn.1006-1959.2024.17.027]
　LUO Ai-lian.Effect of Dingkundan Combined with Diane-35 on Signs and Hormone Levels in Patientswith Polycystic Ovary Syndrome[J].Journal of Medical Information,2024,37(03):127.[doi:10.3969/j.issn.1006-1959.2024.17.027]

更新日期/Last Update: 1900-01-01